Experimental conduction block induced by serum from a patient with anti‐GM1 antibodies

Increased titers of antibodies to GM1 ganglioside in humans are associated with lower motor neuron disease and predominantly motor neuropathy with or without conduction block. To investigate the possible mechanism of these antibodies, we injected the serum of a patient with anti‐GM1 antibodies who had motor neuron disease and multifocal motor conduction block, into rat sciatic nerve. When injected with fresh human complement, the serum‐induced conduction block with temporal dispersion and deposits of immunoglobulin were detected at the nodes of Ranvier. Electron microscopic studies revealed demyelination in 6.5% of the fibers. After preabsorbtion with GM1, the serum had no effect, suggesting that the anti‐GM1 antibodies were responsible for the conduction abnormalities.

[1]  A. Hays,et al.  IgM deposits at nodes of ranvier in a patient with amyotrophic lateral sclerosis, anti‐GM1 antibodies, and multifocal motor conduction block , 1990, Annals of neurology.

[2]  G. Legname,et al.  Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high‐molecular‐weight neural‐specific glycoproteins , 1990, Annals of neurology.

[3]  J. England,et al.  A computer simulation of conduction block: Effects produced by actual block versus interphase cancellation , 1990, Annals of neurology.

[4]  L. Berg,et al.  The spectrum of neurologic disease associated with anti‐GM1 antibodies , 1990, Neurology.

[5]  M. Routbort,et al.  Polyclonal IgM anti‐GM1 ganglioside antibody in patients with motor neuron disease and variants , 1990, Annals of neurology.

[6]  G. Parry,et al.  Lower motor neuron disease in a patient with auto‐antibodies against Gal(β 1‐3)GalNAc in gangliosides GM1 and GD1b , 1990, Neurology.

[7]  P R Smith,et al.  Expression of myelin basic protein isoforms in nonglial cells , 1990, The Journal of cell biology.

[8]  A. Pestronk,et al.  Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies , 1990, Annals of neurology.

[9]  L. H. van den Berg,et al.  Human Monoclonal IgM Anti-Gal(β1-3)GalNAc Autoantibodies Bind to the Surface of Bovine Spinal Motoneurons , 1990, Journal of neuropathology and experimental neurology.

[10]  A. Pestronk,et al.  Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy , 1989, Journal of Neuroimmunology.

[11]  R. Lovelace,et al.  Electrophysiologic study of experimental demyelination induced by serum of patients with IgM M proteins and neuropathy , 1989, Neurology.

[12]  N. Latov,et al.  Monoclonal IgMs with anti-Gal(β1–3)GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins , 1989, Journal of Neuroimmunology.

[13]  R. Knobler,et al.  Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia , 1989, Annals of neurology.

[14]  S. Kusunoki,et al.  Motor dominant neuropathy and IgM paraproteinemia: the IgM M-protein binds to specific gangliosides , 1989, Journal of Neuroimmunology.

[15]  A. Hays,et al.  Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron disease , 1989, Journal of Neuroimmunology.

[16]  N. Latov,et al.  Monoclonal IgM in two patients with motor neuron disease bind to the carbohydrate antigens Gal(β1–3)GalNAc and Gal(β1–3)GlcNAc , 1988, Journal of Neuroimmunology.

[17]  M. Dalakas,et al.  Identification and Characterization of Gangliosides Reacting with IgM Paraproteins in Three Patients with Neuropathy Associated with Biclonal Gammopathy , 1988, Journal of neurochemistry.

[18]  J. England,et al.  Tellurium‐induced demyelination: An electrophysiological and morphological study , 1988, Muscle & nerve.

[19]  E. Kabat,et al.  Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto‐N ‐tetraose associated with human motor neuron disease , 1988, Neurology.

[20]  A. Steck,et al.  Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b , 1988, Annals of neurology.

[21]  A. Hays,et al.  Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti‐MAG IgM M‐protein , 1987, Neurology.

[22]  A. Hays,et al.  Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease , 1986, Neurology.

[23]  R. Nemni,et al.  Immunofluorescence study of patients with neuropathy and IgM M proteins , 1985, Annals of neurology.

[24]  S. Spicer,et al.  Histochemical localization of galactose-containing glycoconjugate at peripheral nodes of Ranvier in the rat. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[25]  D. Kirschner,et al.  Ganglioside localization on myelinated nerve fibres by cholera toxin binding , 1983, Journal of neurocytology.

[26]  D. Silberberg,et al.  Acute conduction block associated with experimental antiserum‐mediated demyelination of peripheral nerve , 1982, Annals of neurology.

[27]  M. Rasminsky,et al.  Conduction block in rat myelinated fibres following acute exposure to antigalactocerebroside serum , 1982, The Journal of physiology.

[28]  O. K. Langley,et al.  Histochemistry of Polyanions in Peripheral Nerve , 1979 .

[29]  THE EFFECTS OF EXPERIMENTAL DEMYELINATION ON CONDUCTION IN PERIPHERAL NERVE: A HISTOLOGICAL AND ELECTROPHYSIOLOGICAL STUDY. I. CLINICAL AND HISTOLOGICAL OBSERVATIONS. , 1963, Brain : a journal of neurology.